Quantcast

Latest Low-density lipoprotein Stories

infertility and high cholesterol
2014-05-21 05:21:38

redOrbit Staff & Wire Reports - Your Universe Online Couples who are having trouble conceiving might want to have their cholesterol levels checked, according to new research published online Tuesday by The Journal of Clinical Endocrinology and Metabolism. According to the study authors, high cholesterol could impair fertility, and couples in which each partner had elevated levels took the longest time to conceive. Furthermore, cases in which the woman had a high cholesterol level...

2014-05-20 04:20:40

BOCA RATON, Fla., May 20, 2014 /PRNewswire/ -- Illness runs rampant throughout America. We do not have any exact numbers of how many people in America are sick, however we do have estimates on the number of Americans with different types of illnesses. We also know that Americans are some of the sickest people on earth. People in the USA suffer from many chronic illnesses that include Cancer, heart disease, diabetes, autoimmune diseases, foodborne illnesses, and more. Photo -...

2014-05-13 23:07:54

Spangenberg Shibley & Liber is now investigating claims on behalf of individuals who allegedly have developed type 2 diabetes after taking statins, a cholesterol lowering medication. Cleveland, OH (PRWEB) May 13, 2014 Spangenberg Shibley & Liber is now investigating claims on behalf of individuals who allegedly have developed type 2 diabetes after taking Lipitor, a cholesterol lowering medication. Lipitor, a brand name for the drug Atorvastatin that was approved by the FDA in...

2014-05-13 16:26:32

THOUSAND OAKS, Calif., May 13, 2014 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the publication of data from the Phase 3 LAPLACE-2 (LDL-C Assessment with PCSK9 MonoclonaL Antibody Inhibition Combined with Statin ThErapy-2) study in the Journal of the American Medical Association (JAMA). Results from the 12-week study, which evaluated 1,896 patients with high cholesterol, showed treatment with subcutaneous evolocumab (140 mg every two weeks or 420 mg monthly) in combination with...

2014-05-07 12:30:30

WOODBRIDGE, ON, May 7, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced today that the U.S. Patent and Trademark Office (USPTO) has issued Patent Number 8,715,648 titled "Formulations Comprising Omega-3 Fatty Acids and Anti-Obesity Agent for the Reduction of Body Weight in Cardiovascular Disease Patients (CVD) and Diabetics"....

2014-05-06 04:23:22

WILMINGTON, Del., May 6, 2014 /PRNewswire/ -- AstraZeneca (NYSE: AZN) today announced the US Food and Drug Administration (FDA) approved EPANOVA(®) (omega-3-carboxylic acids) as an adjunct to diet to reduce triglyceride levels in adults with severe hypertriglyceridemia (triglyceride levels greater than or equal to 500 mg/dL). To view the multimedia assets associated with this release, please click: http://www.multivu.com/mnr/7192251-astrazeneca-fda-approval EPANOVA is the first FDA approved...

2014-05-02 08:25:43

Data suggest lower risk of major adverse cardiovascular events and death, especially in patients with diabetes or prior coronary heart disease ORLANDO, Fla., May 2, 2014 /PRNewswire/ -- LipoScience, Inc. (NASDAQ: LPDX), a diagnostic company pioneering a new field of personalized nuclear magnetic resonance (NMR) diagnostics to advance the quality of patient care in cardiovascular, metabolic and other diseases, today announced data suggesting that the use of a target low-density lipoprotein...

2014-05-02 08:24:15

Significant reductions of more than 1,500 mg/dL in triglycerides observed CARLSBAD, Calif., May 2, 2014 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced the final data from its Phase 2 study of ISIS-APOCIII(Rx) as a monotherapy in patients with familial chylomicronemia syndrome, or FCS. In this open-label study, three patients with FCS treated with ISIS-APOCIII(Rx) achieved substantial reductions in triglycerides with all three patients achieving a triglyceride...

2014-05-01 16:31:22

WOODBRIDGE, ON, May 1, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, is pleased to announce that it will be presenting two posters at the American Heart Association's Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) 2014 Scientific Sessions in Toronto, Ontario, Canada, May 1-3, 2014. The first poster entitled "Correlation...

2014-05-01 16:31:16

WOODBRIDGE, ON, May 1, 2014 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) (CSE: PVO), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announces a correction to its press release issued yesterday entitled "Pivotal Therapeutics Announces 2013 Financial Results". The decrease in the loss from 2012 to 2013 of $745,342 was inadvertently overstated by $91,520. The correct decrease in loss is $653,822 and...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related